Skip to main content
Clinical Trials/NL-OMON48345
NL-OMON48345CompletedNot Applicable

Feasibility of a mobile application guiding patients with inflammatory bowel disease during biologic treatment - Mobile application for IBD patients with biologics

Rijnstate Ziekenhuis0 sites55 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
55

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Diagnosis of inflammatory bowel disease (including Crohn*s disease,
  • ulcerative colitis and IBD-unclassified) based on a combination of clinical,
  • endoscopic, histologic and radiologic internationally accepted criteria.
  • - Treatment with biologics, for the purpose of this study only patients with
  • biologics that are administered intravenously in the hospital every 4-10 weeks
  • are included (infliximab or vedoluzimab).
  • - Aged 18 years or older.
  • - Having (access to) a tablet or smartphone.
  • - Having (access to) working internet connection.
  • - Ability to read and understand the Dutch language.

Exclusion Criteria

  • - Patients recently started with biologic treatment (< 3 maanden)
  • - No access to a tablet or smartphone
  • - No internet access

Investigators

Sponsor
Rijnstate Ziekenhuis

Similar Trials